Crohn Disease
Hematopoietic stem-cell transplantation is option for patients with severe CD
Published in Blood Weekly, November 13th, 2003
Some CD patients "fail to respond favorably to the standard treatment, including antibody to tumor necrosis factor alpha (TNF-alpha)," immunotherapists in Chicago explained.
R.M. Craig and colleagues at Northwestern University "embarked on a unique therapy for this group of patients, intense immune suppression followed by autologous hematopoietic stem-cell transplantation (HSCT)."
"The response to this approach in our first four patients has been excellent, with there being no significant untoward event from the transplantation and with each patient...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-11-13)
More Articles from Blood Weekly
- Stem Cells
Scientists find genetic "fountain of youth" for adult hematopoietic cells - Umbilical Cord Blood
Cord blood mast cells release I-309 after IgE exposure - DNA Research
Real-time PCR aids HIV DNA quantification - Liver Transplantation
CVVHD doesn't alter tacrolimus levels in recipients of small-for-size liver grafts - Stem-Cell Research
Multipotent, self-renewing cardiac stem cells identified - Transfusion Medicine
High-throughput NAT screening of donated blood in Japan reviewed - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
